The transition from the EU Clinical Trials Directive (CTD) to the new Clinical Trials Regulation (CTR) represents a major shift in how trials will be conducted across Europe. While this overhaul aims to streamline processes, navigating EU CTR is complex. We have distilled recommendations from the EU Clinical Trials Coordination and Advisory Group (CTAG) into actionable checklists to aid in planning, and our proposed workflow highlights steps to help sponsors navigate the transition process.

You can also download the PDF by clicking the button below

Related Resources

MAY 01, 2022
Regulatory & Compliance

Your Keys to Understanding EU Transparency

A collection of Pink Sheet articles covering evolving EU regulations on clinical trial disclosure and transparency

SEP 01, 2023
White paper
Regulatory & Compliance

Clinical Trial Disclosure Compliance a Moving Target Due to Ever-changing Global Regulations

Gain insights on key factors driving disclosure rule updates and ways to minimize noncompliance risks.

JUN 25, 2023

What You Need to Know About the EU Green Claims Directive

The Pharma R&D Annual Review 2023 Supplement looks at new active substances (NASs), drugs launched onto the market for the first time, during 2022